Yang J, Huang A, Yang K, Jiang K, et al. Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial. BMC Cancer 2023;23:249.
PMID: 36922805